Epigenetic editing refers to the locus-specific targeting of epigenetic enzymes to rewrite the local epigenetic landscape of an endogenous genomic site, often with the aim of transcriptional reprogramming. Implementing clustered regularly interspaced short palindromic repeat-dCas9 greatly accelerated the advancement of epigenetic editing, yielding preclinical therapeutic successes using a variety of epigenetic enzymes. Here, we review the current applications of these epigenetic editing tools in mammals and shed light on biochemical improvements that facilitate versatile applications.
Keywords: CRISPR/dCas; Epigenome editing; Expression reprogramming; Targeted DNA methylation; Targeted histone modifications.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.